Left Brain Wealth Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-30,935
Closed -$842K 82
2023
Q3
$842K Sell
30,935
-2,054
-6% -$57.1K 0.52% 44
2023
Q2
$1,000K Buy
32,989
+961
+3% +$31.1K 0.61% 43
2023
Q1
$1.17M Buy
32,028
+9,692
+43% +$306K 0.79% 40
2022
Q4
$627K Buy
+22,336
New +$640K 0.47% 46

Other funds holding EVH

Left Brain Wealth Management's EVH Position: Q4 2023 in Review

Left Brain Wealth Management sold out of Evolent Health (EVH) in Q4 2023, closing a stake of 30,935 shares — an estimated $842K sold.

Left Brain Wealth Management first reported a position in EVH in Q4 2022 and held it in 4 quarters. The position peaked at $1.17M in Q1 2023. 234 funds tracked by Wall St. Rank hold EVH as of Q4 2023.

  • Left Brain Wealth Management reported no remaining Evolent Health position as of Q4 2023 after selling out during the quarter.
  • Left Brain Wealth Management sold 30,935 Evolent Health shares in Q4 2023, an estimated $842K.
  • Left Brain Wealth Management first reported a position in Evolent Health in Q4 2022 and held it in 4 quarters.
  • Left Brain Wealth Management's Evolent Health position peaked at $1.17M in Q1 2023.
  • 234 funds tracked by Wall St. Rank held Evolent Health as of Q4 2023.

Based on Left Brain Wealth Management's 13F filing for Q4 2023, filed 14 Feb 2024.